AdaptHealth Boosts Liquidity With New $1.1 Billion Credit Facility

The latest update is out from AdaptHealth ( (AHCO) ).

On April 10, 2026, AdaptHealth LLC, a subsidiary of AdaptHealth Corp., entered into a new senior secured credit agreement totaling $1.1 billion, comprising a $325 million term loan, a $325 million delayed-draw term loan and a $450 million revolving credit facility with extended maturities to April 2031. The facility, guaranteed and secured by substantially all loan party assets, features leverage- and coverage-based covenants, lower SOFR-linked pricing tiers and flexibility for incremental debt, with initial term loan proceeds used to refinance prior bank debt and providing capacity to refinance 2028 senior notes and fund acquisitions.

AdaptHealth disclosed on April 13, 2026, that the refinancing replaces its previous term loan and upsizes its revolver from $300 million to $450 million, enhancing liquidity for working capital, capital expenditures and M&A while allowing early redemption of 6.125% senior notes due 2028 to cut interest expense. Management highlighted recent upgrades from S&P and Moody’s, a well-oversubscribed syndication and a reduced pricing grid as evidence of stronger credit quality, and indicated that the transaction extends the company’s debt maturity profile, lowers its weighted average cost of debt and strengthens financial flexibility without altering its full-year 2026 guidance.

The most recent analyst rating on (AHCO) stock is a Buy with a $13.00 price target. To see the full list of analyst forecasts on AdaptHealth stock, see the AHCO Stock Forecast page.

Spark’s Take on AHCO Stock

According to Spark, TipRanks’ AI Analyst, AHCO is a Neutral.

The score is driven primarily by strong cash generation but tempered by volatile financial performance (sharp TTM revenue decline and net loss) and ongoing leverage risk. Technicals are supportive with price above major moving averages and positive momentum. Earnings call guidance and the capitated contract provide a constructive forward outlook, while valuation remains pressured due to losses (negative P/E).

To see Spark’s full report on AHCO stock, click here.

More about AdaptHealth

AdaptHealth Corp., based in Conshohocken, Pa., is a national provider of patient-centered healthcare-at-home solutions, supplying home medical equipment, medical supplies and related services across four segments: Sleep Health, Respiratory Health, Diabetes Health and Wellness at Home. The company serves roughly 4.3 million patients annually through about 640 locations in 48 states, working with a broad network of hospitals, physicians, sleep labs and other referral sources and serving Medicare, Medicaid and commercial payors.

AdaptHealth focuses on products such as CPAP and BiPAP devices for sleep apnea, oxygen and home ventilation equipment for chronic respiratory conditions, continuous glucose monitors and insulin pumps for diabetes, and a range of durable medical equipment for patients transitioning from acute care or managing complex disease states at home. Its diversified product mix and nationwide footprint position the company as a major player in the U.S. home medical equipment and supplies market, with growth tied to aging demographics, chronic disease trends and the shift of care to the home setting.

Average Trading Volume: 1,318,819

Technical Sentiment Signal: Buy

Current Market Cap: $1.65B

Learn more about AHCO stock on TipRanks’ Stock Analysis page.